Apoptosis-related gene expression in benign prostatic hyperplasia and prostate carcinoma

Anticancer Research

Volumn 26, Issue 3 A, 2006, Pages 1849-1854

  Iacopino, F ^a   Angelucci, C ^a   Lama, G ^a   Zelano, G ^a   La Torre, G ^a   D'Addessi, A ^a   Giovannini, C ^b   Bertaccini, A ^b   Macaluso, M Pavone ^c   Martorana, G ^b   Sica, Gigliola ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

Author keywords

Apoptosis; Benign prostatic hyperplasia; Prostate cancer

Indexed keywords

FAS ANTIGEN; MYC PROTEIN; PROTEIN BAX; PROTEIN BCL 2;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER STAGING; CELL DEATH; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE EXPRESSION; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; ONCOGENE C MYC; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; ANTIGENS, CD95; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; GENE EXPRESSION; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MYC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 33745616097     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Majno G and Joris I: Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 146: 3-15, 1995.
2. Tang DG and Porter AT: Target to apoptosis: a hopeful weapon for prostate cancer. Prostate 32: 284-293, 1997.
3. Bruckheimer EM and Kyprianou N: Apoptosis in prostate carcinogenesis. A growth regulator and a therapeutic target. Cell Tissue Res 301: 153-162, 2000.
4. Lu QL, Abel P, Foster CS and Lalani EN: Bcl-2: role in epithelial differentiation and oncogenesis. Hum Pathol 27: 102-110, 1996.
5. McDonnell TJ, Troncoso P, Brisbay SM, Logothetis C, Chung LWK, Hsieh JT, Tu SM and Campbell ML: Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res 52: 6940-6944, 1992.
6. Bubendorf L, Sauter G, Moch H, Jordan P, Blöchlinger A, Gasser TC and Mihatsch MJ: Prognostic significance of bcl-2 in clinically localized prostate cancer. Am J Pathol 148: 1557-1565, 1996.
7. Gross A, Jockel J, Wei MC and Korsmeyer SJ: Enforced dimerization of bax results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J 17: 3878-3885, 1998.
8. Oltvai ZN, Milliman CL and Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death. Cell 74: 609-619, 1993.
9. Krajewski S, Blomqvist C, Franssila K, Krajewska M, Wasenius VM, Niskanen E, Nordling S and Reed JC: Reduced expression of proapoptotic gene bax is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. Cancer Res 55: 4471-4478, 1995.
10. Chresta CM, Masters JR and Hickman JA: Hypersensitivity of human testicular tumors to etoposide-induced apoptosis is associated with functional p53 and a high bax:bcl-2 ratio. Cancer Res 56: 1834-1841, 1996.
11. Mackey TJ, Borkowski A, Amin P, Jacobs SC and Kyprianou N: Bcl-2/bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with prostate cancer. Urology 52: 1085-1090, 1998.
12. Nagata S: Fas and fas ligand: a death factor and its receptor. Adv Immunol 57: 129-144, 1994.
13. Uslu R, Borsellino N, Frost P, Garban H, Ng CP, Mizutani Y, Belldegrun A and Bonavida B: Chemosensitization of human prostate carcinoma cell lines to anti-fas-mediated cytotoxicity and apoptosis. Clin Cancer Res 3: 963-972, 1997.
14. Nupponen NN, Kakkola L, Koivisto P and Visakorpi T: Genetic alterations in hormone-refractory recurrent prostate carcinomas. Am J Pathol 155: 141-148, 1998.
15. Bernard D, Pourtier-Manzanedo A, Gil J and Beach DH: Myc confers androgen-independent prostate cancer cell growth. J Clin Invest 112: 1724-1731, 2003.
16. Angelucci C, Iacopino F, Lama G, Zelano G, Gianesini G, Sica G and Bono AV: Reverse transcriptase-PCR analysis of apoptosis regulating gene expression in human benign prostatic hyperplasia. Anticancer Res 25: 3937-3942, 2005.
17. Angelucci C, Iacopino F, Lama G, Capucci S, Zelano G, Boca M, Pistilli A and Sica G: Apoptosis-related gene expression affected by a GnRH analogue without induction of programmed cell death in LNCaP cells. Anticancer Res 24: 2729-2738, 2004.
18. Sasaki Y, Ahmed H, Takeuchi T, Moriyama N and Kawabe K: Immunohistochemical study of Fas, Fas ligand and interleukin-1 beta converting enzyme expression in human prostatic cancer. Br J Urol 81: 852-855, 1998.
19. Savinainen KJ, Linja MJ, Saramaki OR, Tammela TL, Chang GT, Brinkmann AO and Visakorpi T: Expression and copy number analysis of TRPS1, EIF3S3 and MYC genes in breast and prostate cancer. Br J Cancer 90: 1041-1046, 2004.
20. Royuela M, De Miguel MP, Bethencourt FR, Fraile B, Arenas MI and Paniagua R: IL-2, its receptors, and bcl-2 and bax genes in normal, hyperplastic and carcinomatous human prostates: immunohistochemical comparative analysis. Growth Factors 18: 135-146, 2000.
21. Zhou JR, Yu L, Zerbini LF, Libermann TA and Blackburn GL: Progression to androgen-independent LNCaP human prostate tumors: cellular and molecular alterations. Int J Cancer 110: 800-806, 2004.
22. Fonseca-Moutinho JA, Cruz E, Carvalho L, Prazeres HJM, De Lacerda MMP, Da Silva DP, Mota F and De Oliveira CF: Estrogen receptor, progesterone receptor, and bcl-2 are markers with prognostic significance in CIN III. Int J Gynecol Cancer 14: 911-920, 2004.
23. Scopa CD, Vagianos C, Kardamakis D, Kourelis TG, Kalofonos HP and Tsamandas AC: Bcl-2/bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with rectal cancer. Appl Immunohistochem Mol Morphol 9: 329-334, 2001.
24. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ and Hancock DC: Induction of apoptosis in fibroblasts by c-myc protein. Cell 69: 119-128, 1992.